NCT03609125View on ClinicalTrials.gov

Cord Blood Serum in the Treatment of Neuro-Degenerative Ophthalmic Diseases. 1-Glaucoma

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

September 30, 2023

Study Completion Date

December 31, 2023

Conditions
GlaucomaNeuro-Degenerative Disease
Interventions
OTHER

CBS eyedrop

The product is dispensed as sterile frozen vials containing 0.8 ml of product for the daily administration. The product is thawed and administered at a dose of 1 drop / 8 times each eye during the waking period.

Trial Locations (1)

40138

IRCCS AOUBO, Ophthalmology Unit, Bologna

All Listed Sponsors
collaborator

University of Bologna

OTHER

lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

NCT03609125 - Cord Blood Serum in the Treatment of Neuro-Degenerative Ophthalmic Diseases. 1-Glaucoma | Biotech Hunter | Biotech Hunter